Only 30 cases of non-invasive intra-capsular carcinoma ex pleomorphic adenoma have been reported in the English language literature [1] [2] [3] [4] [5] . Here, we report three cases of noninvasive carcinoma ex pleomorphic adenoma and we have carried out a literature survey. The prognosis and therapeutic appoach will depend on evidence of capsular invasion. HER-2/neu is a useful marker in the differential diagnosis of pleomorphic adenoma versus noninvasive carcinoma ex pleomorphic adenoma.
therapy. The patient was monitored and remained well and without evidence of disease for 70 months after the surgery.
Case 2
A 72-year-old man was admitted to hospital, presenting with a non-painful mass in the and without evidence of disease for 37 months after the surgery.
Case 3
A 57-year-old man was admitted to hospital, presenting with a non-painful mass of the 
Discussion
Pleomorphic adenoma is the most common salivary gland neoplasm ; it infrequently undergoes malignant transformation. The propensity for malignant transformation by either clinical or histological criteria is 1.9-23.3% and carcinoma ex pleomorphic adenoma represents approximately 12% of all malignant salivary gland tumors 4 5 . Although the ratio of malignant transformation is unclear in the salivary gland tumors we have examined in the last 10 years, we identi ed 155 pleomorphic adenomas and 15 carcinoma ex pleomorphic adenomas. Carcinoma ex pleomorphic adenomas are generally divided into three histopathological types : noninvasive, minimally invasive less than 1.5 mm of invasion beyond the lesional capsule , and invasive type 6 . In our 15 cases of carcinoma ex pleomorphic adenoma, three cases of noninvasive type, no case of minimally invasive type, and 12 cases Thirty cases of noninvasive intracapsular carcinoma ex pleomorphic adenoma have been reported previously but the features of four of those cases were not reported in detail 2-5 7 8 .
We compared the clinical pathologic features of 30 cases previously reported with the three cases reported here Table 1 HER-2/neu expression, which is a marker of malignant salivary gland tumors, was examined in a total of 14 cases, including 11 previous cases and the three cases reported in this study. Twelve cases were positive for HER-2/neu and the two negative cases were noninvasive myoepithelial carcinoma ex pleomorphic adenoma cases arising in myoepithelial cells.
We conclude that pleomorphic adenoma with focal areas showing malignant changes should be carefully assessed by serial sectioning to obtain evidence of capsular invasion, which agrees with previous reports 2 5 . The prognosis and therapeutic approach depend on the evidence of capsular invasion. HER-2/neu is a useful marker in the differential diagnosis of pleomorphic adenoma versus noninvasive carcinoma ex pleomorphic adenoma. This is especially true when there a suspicion that the pleomorphic adenoma includes a malignant component or shows malignant transformation 7 . Recent studies have revealed that the androgen receptor AR , Ki-67, and p53 may also be useful markers for this differential diagnosis, although they were not examined in this study.
